Potential years of life lost due to urogenital cancer in the United States: Trends from 1972 to 2006 based on data from the SEER database

Journal of Urology

Volumn 187, Issue 3, 2012, Pages 868-871

  Kamel, Mohamed H ^a   Moore, Page C ^a   Bissada, Nabil K ^a   Heshmat, Samy M ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

kidney; mortality; neoplasms; SEER program; urogenital system

Indexed keywords

ARTICLE; BLADDER CANCER; CALCULATION; CANCER MORTALITY; FEMALE; GENDER; HEALTH CARE POLICY; HUMAN; KIDNEY CANCER; KIDNEY PELVIS CARCINOMA; MALE; MORTALITY; PENIS CANCER; POTENTIAL YEAR OF LIFE LOST; PREMATURE MORTALITY; PRIORITY JOURNAL; PROSTATE CANCER; REFERENCE DATABASE; STATISTICAL SIGNIFICANCE; TESTIS CANCER; UNITED STATES; URETER CANCER; UROGENITAL TRACT CANCER; UROLOGIST;

ADULT; AGED; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MORTALITY, PREMATURE; SEER PROGRAM; UNITED STATES; UROGENITAL NEOPLASMS;

EID: 84857060145     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.10.142     Document Type: Article

References (18)

1. A. Jemal, R. Siegel, E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
2. K.R. Yabroff, C.J. Bradley, A.B. Mariotto Estimates and projections of value of life lost from cancer deaths in the United States J Natl Cancer Inst 17 2008 1755
3. Surveillance Epidemiology and End Results National Cancer Institute www.seer.cancer.gov Accessed 2011
4. P. O'Lorcain, P.M. Walsh, H. Comber Cumulative cancer mortality risk and potential years of life lost to 64 years of age in Ireland, 19532002 Eur J Cancer Prev 16 2007 167
5. National Vital Statistics Reports Publications and Information Products. Centers for Disease Control and Prevention http://www.cdc.gov/nchs/products/ pubs/pubd/nvsr/51/51-03.htm Accessed September 1, 2011
6. K.D. Kochanek, J. Xu, S.L. Murphy Deaths: Preliminary Data for 2009 National Vital Statistics Reports, vol. 59, No. 4 http://www.cdc.gov/nchs/data/ nvsr/nvsr59/nvsr59-04.pdf Accessed September 1, 2011
7. J.W. Horm, E.J. Sondik Person-years of life lost due to cancer in the United States, 1970 and 1984 AJPH 79 1989 1490
8. A.J. Pantuck, A. Zisman, A.S. Belldegrun The changing natural history of renal cell carcinoma J Urol 166 2001 1611
9. T. Gudbjartsson, A. Thoroddsen, V. Petursdottir Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients Urology 66 2005 1186
10. E. Jonasch, P. Corn, L.C. Pagliaro Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis Cancer 116 2010 57
11. A.I. Sagolowski, T.W. Jarrett, R.C. Flanigan Urothelial tumors of the upper urinary tract A.J. Wein, L.R. Kavoussi, A.C. Novick, 10th ed. Campbell-Walsh Urology vol 2 2011 Saunders Elsevier Philadelphia 1516 chapt 53
12. S. Gori, S. Porrozzi, F. Roila Germ cell tumours of the testis Crit Rev Oncol Hematol 53 2005 141
13. S.F. Shariat, P.I. Karakiewicz, G.S. Palapattu Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Consortium J Urol 176 2006 2414
14. R. Abouassaly, S.M. Alibhai, N. Shah Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma Urology 76 2010 895
15. F.H. Schroder, J. Hugosson, M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320
16. G.L. Andriole, E.D. Crawford, R.L. Grubb 3rd Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310
17. D. Ilic, D. O'Connor, S. Green Screening for prostate cancer: an updated Cochrane systematic review BJU Int 107 2011 882
18. B.Y. Hernandez, J. Barnholtz-Sloan, R.R. German Burden of invasive squamous cell carcinoma of the penis in the United States, 19982003 Cancer, suppl. 15 2008 2883